Energean PLC

Declaration of Voting Results & Voting Rights Announcements • Oct 11, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8010D

Energean Oil & Gas PLC

11 October 2018

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

ENERGEAN OIL & GAS PLC

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Clal Insurance Company Ltd.

4. Full name of shareholder(s) (if different from 3.)v

Name

N/A

City and country of registered office (if applicable)

5. Date of the transaction and date on which the threshold is crossed or reached:

28 September 2018

6. Date on which issuer notified (DD/MM/YYYY):

10 October 2018

7. Threshold(s) that is/are crossed or reached: vi, vii

Below 11%

8. Notified details

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of Voting Rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary shares

17,622,268

11.53%

855,044

855,044

15,608,034

0.56%

10.21%

B: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expiration

datex

Exercise/

Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Type of financial instrument

Exercise Price

Expiration

datex

Exercise/

Conversion Period xi

Number of voting rights instrument refers to

% of voting rights

N/A

Nominal

Data

Total (A+B+C)
Number of voting rights	Percentage of voting rights
16,463,078	10.77%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Clal Insurance Company Ltd. ("Clal") controls directly or indirectly the voting rights attached to a total of 16,463,078 ordinary shares in Energean Oil & Gas Plc ("Energean") through several of its controlled undertakings, as stated below: Of total of 16,463,078 ordinary shares (a) 855,044 Ordinary Shares are beneficially held for its own account; and (b) 15,608,034 Ordinary Shares are held for members of the public through, among others, provident funds and/or pension funds and/or insurance policies, which are managed by Clal and subsidiaries of Clal (Clal Pension and Provident funds Ltd. and Atudot Pension Fund for Workers & Independent Workers Ltd.) which operates under independent management and make independent voting and investment decisions. The 16,463,078 ordinary shares represent 10.77% of the voting rights attached to Energean's shares (based on the total number of issued shares in Energean being 152,823,238 ordinary shares).
10. In case of proxy voting, please identify:
Name of the proxy holder	N/A
The number and % of voting rights held	N/A
The date until which the voting rights will be held	N/A
11. Additional informationxvi
N/A

Contact name:	Adi Barkan Stern Company Secretary Clal Insurance Enterprises Holdings Ltd
Contact Telephone:	+972-3-6387634

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

HOLEALEFFSKPFFF